Abstract:Aging in females is not only associated with the changes in hormonal status but is also responsible for dysregulation of immune functions in various organs including ovaries. The goal of this study was to determine whether the expression of interleukin 16 (IL-16), a proinflammatory and chemoattractant cytokine, changes during ovarian aging, to determine factors involved in such changes in IL-16 expression, and to examine if changes in IL-16 expression during aging predisposes the ovary to pathologies. Ovarian tissues from premenopausal women (30-50 years old), women at early menopause (55-59 years old), and late menopause (60-85 years old) were used. In addition, tumor tissues from patients with ovarian high-grade serous carcinoma at early stage ( n = 5 ) were also used as reference tissue for comparing the expression of several selected markers in aging ovaries. The expression of IL-16, frequency of macrophages (a source of IL-16) and expression of microRNA (miR) 125a-5p (a regulator of IL-16 gene) were performed by immunohistochemistry, immunoblotting, and gene expression assays. In addition, we examined changes in nuclear expression of IL-16 expression with regards to exposure to follicle-stimulating hormone (FSH) by in vitro cell culture assays with human ovarian cancer cells. The frequencies of IL-16 expressing cells were significantly higher in ovarian stroma in women at early and late menopause as compared with premenopausal women ( P < 0.0001 ). Similar patterns were also observed for macrophages. Expression of miR-125a-5p decreased significantly ( P < 0.001 ) with the increase in IL-16 expression during aging. Furthermore, expression of nuclear IL-16 increased remarkably upon exposure to FSH. Consequently, ovarian aging is associated with increased expression of IL-16 including its nuclear fraction. Therefore, persistent high levels of FSH in postmenopausal women may be a factor for enhanced expression of IL-16. Effects of increased nuclear fraction of IL-16 need to be examined.

Unveiling the role of chronic inflammation in ovarian aging: insights into mechanisms and clinical implications

Inflamm-Aging: A New Mechanism Affecting Premature Ovarian Insufficiency

The influence of the gut microbiome on ovarian aging

New insight into the role of macrophages in ovarian function and ovarian aging

Macrophage multinucleated giant cells: hallmarks of the aging ovary.

Current Understanding of Ovarian Aging

Single-cell analysis of ovarian myeloid cells identifies aging associated changes in macrophages and signaling dynamics

Single-cell analysis of the aged ovarian immune system reveals a shift towards adaptive immunity and attenuated cell function

Ovarian aging: mechanisms and intervention strategies

Changes in IL-16 Expression in the Ovary during Aging and Its Potential Consequences to Ovarian Pathology

Unveiling uterine aging: Much more to learn

The Role of Oxidative Stress and Natural Antioxidants in Ovarian Aging

Fibroinflammatory Signatures Increase with Age in the Human Ovary and Follicular Fluid

The role of oxidative stress in ovarian aging: a review

Female germline stem cells: aging and anti-aging

Impacts of endometrioma on ovarian aging from basic science to clinical management

Mechanisms of ovarian aging in women: a review

[Advances in the study of ovarian dysfunction with aging]

The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities

Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging

Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes